Oridonin reduces cisplatin-induced cardiac damage: targeting oxidative stress and inflammation in chemotherapy.

Cisplatin is a potent chemotherapeutic agent widely used in cancer treatment, known for its efficacy but limited by significant cardiotoxic side effects. Oridonin, a bioactive diterpenoid derived from Rabdosia rubescens, has demonstrated potential to…

Preview only. Read the full abstract at the source